Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TG Therapeutics Inc (NASDAQ:TGTX)

17.45
Delayed Data
As of Jul 31
 +0.39 / +2.29%
Today’s Change
7.20
Today|||52-Week Range
20.00
+10.16%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close17.06
Today’s open17.09
Day’s range17.00 - 17.85
Volume263,342
Average volume (3 months)609,135
Market cap$883.6M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-102.47%
Earnings growth (this year)+22.87%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales3,541.46
Price/Book9.79

Competitors

 Today’s
change
Today’s
% change
NWBONorthwest Biotherape...+0.08+0.71%
XNCRXencor Inc+0.04+0.18%
SGYPSynergy Pharmaceutic...+0.53+6.17%
EPZMEpizyme Inc-0.02-0.09%
Data as of 3:59pm ET, 07/31/2015

Financials

Last reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$152.4K
Annual profit (last year)-$55.8M
Net profit margin-36,606.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael S. Weiss
CFO, Secretary, Treasurer &
CAO
Sean A. Power
Corporate headquarters
New York, New York

Forecasts